乐
乐观
乐观 · 25%PHGE
$0.42
情景价格
$1.850
+0.263 (+14.20%)收盘时
Loading chart…
- 最高
- 2.158
- 开盘
- 1.660
- 成交量加权均价
- 1.89
- 成交量
- 3.40M
- 市值
- 23.61M
- 最低
- 1.650
- 成交额
- 6.41M
- 企业价值/息税折旧摊销前利润（TTM）
- 0.00
Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.
AI 分析 of BiomX Inc (PHGE)
持有Biomx Inc (PHGE) is currently not a strong buy due to its significant losses and lack of revenue. The stock is trading at $0.15, down 93.10% year-to-date, indicating severe financial distress. Although the recent acquisition news may provide some positive outlook, the company reported a net income loss of $37.72 million in Q2 2026, which raises concerns about its financial stability. The RSI is at 66.55, suggesting it is nearing overbought territory, which could lead to a pullback. The main risk is the ongoing negative earnings trend, with a forward P/E ratio of 0, indicating no expected profitability in the near future.
估值指标
BiomX Inc（PHGE）当前预期市盈率为 0.00，5 年平均预期市盈率为 -0.87。
Alphio AI 对 PHGE 的价格情景
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重（25 / 50 / 25），不构成保证。
事件时间线
资讯
3.509-04NewsfilterBiomX to Rebrand as Tessera, Launches No-Code AI Command Platform
- 8.509-01Newsfilter
BiomX to Rebrand as Tessera Defense and Homeland Security Inc.
- 7.508-14Newsfilter
BiomX Subsidiary Secures $300,000 Defense Order
8.508-05seekingalphaBiomX Acquires 10% Stake in Motomea to Enhance Drone Testing Capabilities
8.507-28GlobenewswireBiomX Amends Terms of Zorronet Acquisition
PHGE 常见问题 —— 由 Alphio AI 解答
Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers. It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
Biomx Inc (PHGE) is currently not a strong buy due to its significant losses and lack of revenue. The stock is trading at $0.15, down 93.10% year-to-date, indicating severe financial distress. Although the recent acquisition news may provide some positive outlook, the company reported a net income loss of $37.72 million in Q2 2026, which raises concerns about its financial stability. The RSI is at 66.55, suggesting it is nearing overbought territory, which could lead to a pullback. The main risk is the ongoing negative earnings trend, with a forward P/E ratio of 0, indicating no expected profitability in the near future.
社区
更多 ↗暂无帖子
注册或登录后参与讨论本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。